Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A

FEBS Letters

Volumn 583, Issue 17, 2009, Pages 2772-2778

  Dinarina, Ana ^a   Santamaria, Patricia G ^a   Nebreda, Angel R ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

CDK; Cell cycle; Cyclin; RINGO Speedy; Ubiquitination

Indexed keywords

CYCLIN DEPENDENT KINASE ACTIVATING KINASE; RINGO A PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHROMOSOME CONDENSATION; CONTROLLED STUDY; CYTOKINESIS; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; SOMATIC CELL; UBIQUITINATION;

ANIMALS; CADHERINS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; HUMANS; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS;

MAMMALIA;

EID: 69249203463     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.07.028     Document Type: Article

References (24)

1. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
2. Koepp D.M., Schaefer L.K., Ye X., Keyomarsi K., Chu C., Harper J.W., and Elledge S.J. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294 (2001) 173-177
3. Yu Z.K., Gervais J.L., and Zhang H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc. Natl. Acad. Sci. USA 95 (1998) 11324-11329
4. King R.W., Peters J.M., Tugendreich S., Rolfe M., Hieter P., and Kirschner M.W. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81 (1995) 279-288
5. Geley S., Kramer E., Gieffers C., Gannon J., Peters J.M., and Hunt T. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153 (2001) 137-148
6. Chang D.C., Xu N., and Luo K.Q. Degradation of cyclin B is required for the onset of anaphase in Mammalian cells. J. Biol. Chem. 278 (2003) 37865-37873
7. Li J., Meyer A.N., and Donoghue D.J. Requirement for phosphorylation of cyclin B1 for Xenopus oocyte maturation. Mol. Biol. Cell 6 (1995) 1111-1124
8. Dinarina A., Perez L.H., Davila A., Schwab M., Hunt T., and Nebreda A.R. Characterization of a new family of cyclin-dependent kinase activators. Biochem. J. 386 (2005) 349-355
9. Cheng A., Xiong W., Ferrell Jr. J.E., and Solomon M.J. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. Cell Cycle 4 (2005) 155-165
10. Ferby I., Blazquez M., Palmer A., Eritja R., and Nebreda A.R. A novel p34(cdc2)-binding and activating protein that is necessary and sufficient to trigger G(2)/M progression in Xenopus oocytes. Genes Dev. 13 (1999) 2177-2189
11. Lenormand J.L., Dellinger R.W., Knudsen K.E., Subramani S., and Donoghue D.J. Speedy: a novel cell cycle regulator of the G2/M transition. Embo. J. 18 (1999) 1869-1877
12. Gastwirt R.F., McAndrew C.W., and Donoghue D.J. Speedy/RINGO regulation of CDKs in cell cycle, checkpoint activation and apoptosis. Cell Cycle 6 (2007) 1188-1193
13. Nebreda A.R. CDK activation by non-cyclin proteins. Curr. Opin. Cell Biol. 18 (2006) 192-198
14. Dinarina A., Ruiz E.J., O'Loghlen A., Mouron S., Perez L., and Nebreda A.R. Negative regulation of cell-cycle progression by RINGO/Speedy E. Biochem. J. 410 (2008) 535-542
15. Gutierrez G.J., Vogtlin A., Castro A., Ferby I., Salvagiotto G., Ronai Z., Lorca T., and Nebreda A.R. Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin-proteasome-mediated processing and degradation. Nat. Cell Biol. 8 (2006) 1084-1094
16. Porter L.A., Dellinger R.W., Tynan J.A., Barnes E.A., Kong M., Lenormand J.L., and Donoghue D.J. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J. Cell Biol. 157 (2002) 357-366
17. Eward K.L., Van Ert M.N., Thornton M., and Helmstetter C.E. Cyclin mRNA stability does not vary during the cell cycle. Cell Cycle 3 (2004) 1057-1061
18. Koepp D.M., Harper J.W., and Elledge S.J. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97 (1999) 431-434
19. Pines J., and Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 346 (1990) 760-763
20. Potapova T.A., Daum J.R., Pittman B.D., Hudson J.R., Jones T.N., Satinover D.L., Stukenberg P.T., and Gorbsky G.J. The reversibility of mitotic exit in vertebrate cells. Nature 440 (2006) 954-958
21. Frescas D., and Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8 (2008) 438-449
22. Al Sorkhy M., Craig R., Market B., Ard R., and Porter L.A. The cyclin-dependent kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4. J. Biol. Chem. 284 (2009) 2617-2627
23. Wolf F., Wandke C., Isenberg N., and Geley S. Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. Embo. J. 25 (2006) 2802-2813
24. De Boer L., Oakes V., Beamish H., Giles N., Stevens F., Somodevilla-Torres M., Desouza C., and Gabrielli B. Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 27 (2008) 4261-4268